[o2–17–05]: rationale for cnp520 dose selection for the pivotal clinical program in preclinical adCristina Lopez‐Lopez,Mike Ufer,Marie‐Laure Rouzade‐Dominguez,Nicole Pezous,Olivier David,Carine Kolly,Pierre Tariot,Eric M. Reiman,Gabriel Vargas,Robert Lenz,Ana Graf,Ulf NeumannAlzheimer's & Dementia(2017)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要